Gilead Sciences Inc (GILD)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	7,605,000	8,260,000	8,474,000	8,838,000	7,330,000	6,003,000	7,008,000	7,225,000	9,918,000	11,629,000	9,788,000	4,559,000	4,071,000	2,513,000	-961,000	4,452,000	4,287,000	4,338,000	8,434,000	8,284,000
Revenue (ttm)	US$ in thousands	26,229,000	26,516,000	26,520,000	26,161,000	26,413,000	26,256,000	26,613,000	26,496,000	26,325,000	26,743,000	26,144,000	25,341,000	24,689,000	23,147,000	22,174,000	22,716,000	22,449,000	22,365,000	22,357,000	22,320,000
Operating profit margin		28.99%	31.15%	31.95%	33.78%	27.75%	22.86%	26.33%	27.27%	37.68%	43.48%	37.44%	17.99%	16.49%	10.86%	-4.33%	19.60%	19.10%	19.40%	37.72%	37.11%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $7,605,000K ÷ $26,229,000K
= 28.99%

The operating profit margin of Gilead Sciences, Inc. has shown a declining trend from Q1 2022 to Q4 2023. The margin decreased from 40.23% in Q4 2022 to 32.49% in Q4 2023. This downward trend may indicate that the company's operating expenses have been increasing at a faster rate than its revenue, impacting its profitability. It is important for the company to closely monitor and manage its operating costs to improve its operating profit margin in the future and enhance its overall financial performance.